Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Analgesia by Single or Dual Acupoints Stimulation After Radical Mastectomy (ASDAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02741726
Recruitment Status : Completed
First Posted : April 18, 2016
Last Update Posted : October 16, 2019
Sponsor:
Information provided by (Responsible Party):
Zhihong LU, Air Force Military Medical University, China

Brief Summary:
The purpose of this study is to compare the effects of dual acupoints and single acupoint transcutaneous electrical acupoint stimulation (TEAS) pretreatment on incidence of Post-Mastectomy Pain Syndrome(PMPS) in patients undergoing operation of breast cancer.

Condition or disease Intervention/treatment Phase
Pain Device: acupoint stimulation Device: no stimulation Not Applicable

Detailed Description:
Patients were randomly assigned to three groups, receiving 30min TEAS before anesthesia respectively. The acupoints of dual point group are bilateral Neiguan points(PC6) combined with Danzhong point(RN17), single point group is bilateral Neiguan points(PC6), and the false stimulation group only attach electrodes without electric current. The frequency of TEAS is set to 2/15 Hz. Intraoperative anesthetic dosage of propofol and remifentanil was recorded. Three and six months after surgery, follow-up about chronic pain was made by telephone or face-to-face using the follow-up questionnaire. The adverse events were recorded.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 593 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effect of Combined-acupoint or Single-acupoint Stimulation Before Surgery on Post Mastectomy Pain: a Multicentre Randomised Controlled Trial
Actual Study Start Date : May 25, 2016
Actual Primary Completion Date : October 23, 2017
Actual Study Completion Date : October 23, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Mastectomy

Arm Intervention/treatment
Experimental: dual acupoint stimulation
The acupoints of dual point group are bilateral Neiguan points(PC6) combined with Danzhong point(RN17), electric stimulation was given through electrode attached to the acupoints.
Device: acupoint stimulation
Electric stimulation was given through electrode attached to acupoints
Other Name: transcutaneous electrical acupoint stimulation

Experimental: single acupoint stimulation
The acupoints of single point group is bilateral Neiguan points(PC6), Electric stimulation was given through electrode attached to the acupoints.
Device: acupoint stimulation
Electric stimulation was given through electrode attached to acupoints
Other Name: transcutaneous electrical acupoint stimulation

Placebo Comparator: no stimulation
false stimulation group only attach electrodes without electric current.
Device: no stimulation
patients were only attached electrodes without electric current




Primary Outcome Measures :
  1. Incidence of chronic pain six months after surgery [ Time Frame: six months after surgery ]

Secondary Outcome Measures :
  1. Incidence of chronic pain three months after surgery [ Time Frame: three months after surgery ]
  2. Remifentanil consumption during the surgery [ Time Frame: from start of surgery to end of surgery, at an average of 2.5 hours ]
  3. the time to the first verbal response [ Time Frame: end of the anesthetics infusion to patient's first response to verbal command,on an average of 30 minutes ]
  4. the time to extubation [ Time Frame: end of the anesthetics infusion to extubation,on an average of 30 minutes ]
  5. postoperative nausea and vomiting within 24 h after surgery [ Time Frame: end of surgery to 24 hours after surgery,on an average of 24 hours ]
  6. respiratory depression within 24 hours after surgery [ Time Frame: end of surgery to 24 hours after surgery,on an average of 24 hours ]
  7. patients' s satisfaction scores on analgesia within 24 hours after surgery [ Time Frame: end of surgery to 24 hours after surgery,on an average of 24 hours ]
  8. Visual Analogue Scale scores within 24 hours after surgery [ Time Frame: end of surgery to 24 hours after surgery,on an average of 24 hours ]
  9. demand of rescue analgesics within 24 hours after surgery [ Time Frame: end of surgery to 24 hours after surgery,on an average of 24 hours ]
  10. pain score at 3m after surgery [ Time Frame: three months after surgery ]
  11. pain score at 6m after surgery [ Time Frame: six months after surgery ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Scheduled for operation of breast cancer;
  • ASA(American Society of Anesthesiologists)I-II;
  • Aged between 18 and 65;
  • Informed consented。

Exclusion Criteria:

  • Suffered from the contraindication of TEAS including the local skin breakage, infection or planted with the electrophysiology device;
  • Unable to communicate and coordinate with the researcher, such as suffering from language comprehension deficits or mental diseases;
  • Certain/suspicious addiction with alcohol, analgesics or other drugs;
  • Unstable Angina or myocardial infarction occurred in 3 months; NYHA(New York Heart Association) is 3 or higher;
  • Blood pressure ≥ 180/110 mm Hg while preoperative visiting;
  • Suffered from diabetic complications including diabetic ketoacidosis, hyperosmolar coma, infection, macroangiopathy, diabetic nephropathy, retinopathy, cardiomyopathy, neuropathy and diabetic foot;
  • Severe dysfunction of liver or kidney meaning one of ALT(Alanine Transaminase), AST(Aspartate Transaminase), ALP(alkaline phosphatase) or TBIL(total bilirubin) is 2 times higher that normal or creatinine clearance < 30 ml/min or serum creatinine > 177umol/L;
  • Participate in the other clinical trial 3 month before the enrollment.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02741726


Locations
Layout table for location information
China, Chongqing
First Afiliated Hospital of Chongqing Medical University
Chongqing, Chongqing, China
China, Henan
People's hospital of Zhengzhou University
Zhengzhou, Henan, China, 450003
First Afiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China, 450052
China, Shaanxi
Tangdu Hospital, Fourth Military Medical University
Xi'an, Shaanxi, China, 710005
First Afiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China, 710022
Xijing Hospital, Fourth Military Medical University
Xi'an, Shaanxi, China, 710032
Sponsors and Collaborators
Zhihong LU
Investigators
Layout table for investigator information
Study Chair: Hailong Dong Air Force Military Medical University, China
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Zhihong LU, Doctor, Air Force Military Medical University, China
ClinicalTrials.gov Identifier: NCT02741726    
Other Study ID Numbers: XJH-A-2016-04-12
First Posted: April 18, 2016    Key Record Dates
Last Update Posted: October 16, 2019
Last Verified: October 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: IPD including those about primary endpoint and secondary endpoints would be available to other researchers.
Supporting Materials: Study Protocol
Statistical Analysis Plan (SAP)
Informed Consent Form (ICF)
Clinical Study Report (CSR)
Time Frame: the data will become available after manuscript published, for 5 years.